511-0000-00L  Drug Discovery and Development

SemesterAutumn Semester 2022
LecturersJ. Hall, U. Thibaut, K.‑H. Altmann, M. Arand, J. Scheuermann, R. Schibli, H. U. Zeilhofer
Periodicityyearly recurring course
Language of instructionEnglish
CommentOnly for MSc Pharmaceutical Sciences.



Courses

NumberTitleHoursLecturers
511-0000-00 GDrug Discovery and Development Special students and auditors need a special permission from the lecturers.
Two-day block course with group work.
14s hrs
08.12.09:15-17:00HG F 26.3 »
09.12.09:15-17:00HG F 26.3 »
U. Thibaut, J. Hall
535-0901-00 SFrom A to Z in Drug Discovery and Development2 hrs
Wed07:45-09:30HCI J 3 »
J. Hall, K.‑H. Altmann, M. Arand, J. Scheuermann, R. Schibli, H. U. Zeilhofer

Catalogue data

AbstractThis course provides an overview over the concepts and processes employed in today's drug discovery and development. It has an introductory character but will also provide more detailed insights employing real life examples. The course combines lectures and interactive elements with active participation of the students.
ObjectiveStudents
- Understand the drug discovery process and can explain major approaches and relevant technical terms (for details see lecture notes).
- Understand and appreciate the content and timing of drug development process steps, development phases and decision criteria.
- Understand the concepts underlying drug product development through all the phases from preclinical and clinical development to regulatory submission, approval and market launch.
- Can differentiate between small molecule drug development and biological drug development.
- Understand the most important differences for drug development and approval between the EU and USA pharma markets with regard to legal and regulatory requirements.
ContentCourse unit comprises weekly lectures covering the early phases of target and drug discovery (535-0901-01 S "From A to Z in Drug Discovery and Development I") with group work in the area of Drug Development (511-0000-00 G). The latter course lasts 2 full days (Days 1 and 2) and comprises both lectures and group work: inter alia an introduction to the entire suite of drug product development processes in the pharmaceutical industry, covering preclinical research and development, clinical development, regulatory processes and market launch.
R&D support processes such as project management, quality management, pharmacovigilance and pharmacoeconomics will be covered as well as organizational and governance aspects of the pharmaceutical industry. In addition, important success factors for a later career in the pharmaceutical industry will be briefly discussed at the end of day 2 of the course.
Lecture notesWill be published on "mystudies"
LiteratureG. Nahler (Hrsg.) Dictionary of pharmaceutical medicine, Springer, Wien, 2013 (3rd edition)
Further readings will be listed in the lecture notes.
Prerequisites / NoticeThis course provides the essential basic knowledge required for the industry-specific modules of the spring semester.

Safety conceptt: Link
CompetenciesCompetencies
Subject-specific CompetenciesConcepts and Theoriesassessed
Techniques and Technologiesassessed
Method-specific CompetenciesProject Managementassessed
Personal CompetenciesAdaptability and Flexibilityassessed
Creative Thinkingassessed
Critical Thinkingassessed
Self-awareness and Self-reflection assessed

Performance assessment

Performance assessment information (valid until the course unit is held again)
Performance assessment as a semester course
ECTS credits2 credits
ExaminersJ. Hall, U. Thibaut
Typegraded semester performance
Language of examinationEnglish
RepetitionRepetition possible without re-enrolling for the course unit.
Admission requirementStudents have attended the weekly lecture course 535-0901-00L (From A to Z in Drug Discovery and Development) and Group Work days 1 and 2.
Additional information on mode of examinationOnline examination and active oral participation during lectures and group work.
Online examinationThe examination may take place on the computer.

Learning materials

No public learning materials available.
Only public learning materials are listed.

Groups

No information on groups available.

Restrictions

General : Special students and auditors need a special permission from the lecturers
PriorityRegistration for the course unit is only possible for the primary target group
Primary target groupPharmaceutical Sciences MSc (512000)

Offered in

ProgrammeSectionType
Pharmaceutical Sciences MasterCore Courses IOInformation